Edgewise Therapeutics Inc
(EWTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,838 | -67,640 | -48,225 | -30,727 | -14,660 |
| Depreciation Amortization | -1,834 | -5 | 1,658 | 1,366 | 797 |
| Accounts payable and accrued liabilities | -160 | 47 | -529 | -1,467 | 1,188 |
| Other Working Capital | -1,991 | 4,086 | -1,401 | -3,471 | -687 |
| Other Operating Activity | 3,997 | 10,877 | 7,717 | 5,482 | 790 |
| Operating Cash Flow | $-22,826 | $-52,635 | $-40,780 | $-28,817 | $-12,572 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,368 | -5,546 | -2,253 | -923 | -369 |
| Purchase Of Investment | 52,803 | -95,605 | -145,697 | 18,937 | 22,923 |
| Sale Of Investment | 607 | 30,574 | 152,969 | 13,326 | 8,832 |
| Investing Cash Flow | $49,042 | $-70,577 | $5,019 | $31,340 | $31,386 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21 | 129,890 | 130,278 | 506 | 73 |
| Other Financing Activity | 0 | -251 | -336 | -254 | 0 |
| Financing Cash Flow | $21 | $129,639 | $129,942 | $252 | $73 |
| Beginning Cash Position | 21,993 | 15,566 | 15,566 | 15,566 | 15,566 |
| End Cash Position | 48,230 | 21,993 | 109,747 | 18,341 | 34,453 |
| Net Cash Flow | $26,237 | $6,427 | $94,181 | $2,775 | $18,887 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,826 | -52,635 | -40,780 | -28,817 | -12,572 |
| Capital Expenditure | -4,368 | -5,546 | -2,253 | -923 | -369 |
| Free Cash Flow | -27,194 | -58,181 | -43,033 | -29,740 | -12,941 |